scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1013100695 |
P356 | DOI | 10.1007/S11926-012-0253-7 |
P698 | PubMed publication ID | 22527950 |
P2093 | author name string | Chad Deal | |
P2860 | cites work | FRAX and the assessment of fracture probability in men and women from the UK | Q24654123 |
Bone versus immune system | Q28140389 | ||
Bone erosions and bone marrow edema as defined by magnetic resonance imaging reflect true bone marrow inflammation in rheumatoid arthritis | Q31107452 | ||
Bone marrow edema | Q33413381 | ||
Up-regulation of TNF-producing T cells in the bone marrow: a key mechanism by which estrogen deficiency induces bone loss in vivo | Q33950241 | ||
Bone mineral density in rheumatoid arthritis patients 1 year after adalimumab therapy: arrest of bone loss | Q34155014 | ||
Estrogen deficiency and bone loss: an inflammatory tale | Q34576622 | ||
Bone erosions in rheumatoid arthritis can be repaired through reduction in disease activity with conventional disease-modifying antirheumatic drugs | Q34897514 | ||
Mechanisms of TNF-alpha- and RANKL-mediated osteoclastogenesis and bone resorption in psoriatic arthritis | Q34967810 | ||
Evaluation of bone mineral density, bone metabolism, osteoprotegerin and receptor activator of the NFkappaB ligand serum levels during treatment with infliximab in patients with rheumatoid arthritis | Q35638087 | ||
Identification of cell types responsible for bone resorption in rheumatoid arthritis and juvenile rheumatoid arthritis | Q35764588 | ||
Impact of low-dose prednisolone on bone synthesis and resorption in early rheumatoid arthritis: experiences from a two-year randomized study | Q37129537 | ||
Osteoimmunology in rheumatic diseases | Q37207025 | ||
The MRI view of synovitis and tenosynovitis in inflammatory arthritis: implications for diagnosis and management | Q37403675 | ||
Osteoclasts and arthritis | Q37532360 | ||
Bone remodeling in rheumatic disease: a question of balance | Q37700811 | ||
Clinical assessment of the long-term risk of fracture in patients with rheumatoid arthritis. | Q38466026 | ||
Bone metabolism changes during anti-TNF-alpha therapy in patients with active rheumatoid arthritis | Q38509480 | ||
Changes in hand and generalised bone mineral density in patients with recent-onset rheumatoid arthritis | Q39841269 | ||
Changes in hand bone mineral density and the association with the level of disease activity in patients with rheumatoid arthritis: bone mineral density measurements in a multicenter randomized clinical trial | Q39998140 | ||
Osteoblast function is compromised at sites of focal bone erosion in inflammatory arthritis | Q46275403 | ||
Preliminary evidence for a structural benefit of the new bisphosphonate zoledronic acid in early rheumatoid arthritis | Q56420412 | ||
Treg cells suppress osteoclast formation: a new link between the immune system and bone | Q56900960 | ||
Denosumab treatment effects on structural damage, bone mineral density, and bone turnover in rheumatoid arthritis: A twelve-month, multicenter, randomized, double-blind, placebo-controlled, phase II clinical trial | Q57752107 | ||
Vertebral deformities in 229 female patients with rheumatoid arthritis: associations with clinical variables and bone mineral density | Q73497690 | ||
High-sensitivity C-reactive protein and risk of nontraumatic fractures in the Bruneck study | Q79422602 | ||
Dickkopf-1 is a master regulator of joint remodeling | Q79610564 | ||
Effect of blockade of TNF-alpha and interleukin-1 action on bone resorption in early postmenopausal women | Q79762888 | ||
Mr Outside and Mr Inside: classic and alternative views on the pathogenesis of rheumatoid arthritis | Q83365780 | ||
P433 | issue | 3 | |
P921 | main subject | rheumatoid arthritis | Q187255 |
P304 | page(s) | 231-237 | |
P577 | publication date | 2012-06-01 | |
P1433 | published in | Current Rheumatology Reports | Q23930052 |
P1476 | title | Bone loss in rheumatoid arthritis: systemic, periarticular, and focal | |
P478 | volume | 14 |
Q36318097 | Association between rheumatoid arthritics and osteoporosis among Chinese men, a community based study |
Q36154527 | Body composition in patients with rheumatoid arthritis is not different than healthy subjects |
Q93190793 | Bone Mineral Loss and Fracture in Sarcoidosis: A Systematic Review and Meta-Analysis |
Q33805455 | Chemokine signals are crucial for enhanced homing and differentiation of circulating osteoclast progenitor cells |
Q39109424 | Comparison of peripheral quantitative computed tomography forearm bone density versus DXA in rheumatoid arthritis patients and controls. |
Q90111774 | Effects of 1-year anti-TNF-α therapies on bone mineral density and bone biomarkers in rheumatoid arthritis and ankylosing spondylitis |
Q88160122 | Effects of once-monthly minodronate versus risedronate in osteoporosis patients with rheumatoid arthritis: a 12-month randomized head-to-head comparison |
Q37725362 | Fractal analysis of subchondral bone changes of the hand in rheumatoid arthritis |
Q44693015 | Gastroesophageal reflux disease in patients with rheumatoid arthritis |
Q35003427 | Hand bone mass in rheumatoid arthritis: A review of the literature |
Q48297258 | Increased chemotaxis and activity of circulatory myeloid progenitor cells may contribute to enhanced osteoclastogenesis and bone loss in the C57BL/6 mouse model of collagen-induced arthritis. |
Q47547933 | Increased frequency of temporal acoustic window failure in rheumatoid arthritis: a manifestation of altered bone metabolism? |
Q36142219 | Increased levels of interleukin 31 (IL-31) in osteoporosis |
Q37409538 | Increased risk of vertebral fracture in patients with rheumatoid arthritis: A meta-analysis |
Q38218977 | Induction of osteoclast progenitors in inflammatory conditions: key to bone destruction in arthritis |
Q87081566 | Juvenile idiopathic arthritis patients and their skeletal status: possible role of vitamin D receptor gene polymorphism |
Q37332300 | Little peptide, big effects: the role of LL-37 in inflammation and autoimmune disease |
Q54995090 | Mesenchymal Stem Cells Promote the Osteogenesis in Collagen-Induced Arthritic Mice through the Inhibition of TNF-α. |
Q38205860 | Novel techniques in the development of osteoporosis drug therapy: the osteoclast ruffled-border vacuolar H(+)-ATPase as an emerging target |
Q58694705 | Osteogenic differentiation of fibroblast-like synovial cells in rheumatoid arthritis is induced by microRNA-218 through a ROBO/Slit pathway |
Q37548012 | Osteoimmunology and Beyond |
Q59793165 | Osteoimmunology of tumor necrosis factor-alpha, IL-6, and RANTES/CCL5: a review of known and poorly understood inflammatory patterns in osteonecrosis |
Q38608511 | Progression rate of severity of aortic stenosis in patients with rheumatoid arthritis |
Q41085878 | Quantitative characterization of metacarpal and radial bone in rheumatoid arthritis using high resolution- peripheral quantitative computed tomography |
Q40330856 | Risk of fragility fracture among patients with sarcoidosis: a population-based study 1976-2013. |
Q28533497 | Sinomenine suppresses osteoclast formation and Mycobacterium tuberculosis H37Ra-induced bone loss by modulating RANKL signaling pathways |
Q28505157 | Targeted disruption of leucine-rich repeat kinase 1 but not leucine-rich repeat kinase 2 in mice causes severe osteopetrosis |
Q89812439 | Tendon and ligament mechanical loading in the pathogenesis of inflammatory arthritis |
Q36515194 | Vitamin D and rheumatoid arthritis |
Search more.